Akadeum Enhances Microbubble Technology for Cell Therapy

Akadeum Advances Microbubble Technology for Cell Therapy Integration
Akadeum Life Sciences, a pioneer in buoyancy-based cell separation technology, showcases its latest progress in microbubble integration at an annual cell therapy conference. The integration of microbubbles into existing cell and gene therapy platforms facilitates significant advancements in both centralized and decentralized cell therapies. This key development aims to streamline processes, reduce operational footprint, and lower costs, ultimately enhancing the efficiency of cell therapy manufacturing.
Key Benefits of Microbubble Integration
By employing microbubble technology, Akadeum delivers a remarkable reduced footprint for cell therapy manufacturing. This allows facilities to operate more efficiently whilst maintaining high-quality outcomes for cell separation. The seamless integration capabilities mean that both manual and automated systems can benefit from this innovative approach, leading to healthier cells and improved overall processes.
Participation in ASGCT Conference
Akadeum is attending the annual American Society of Gene & Cell Therapy (ASGCT) event to present these advancements. Throughout the conference, various discussions and presentations highlight the potential of microbubbles in the evolution of cell therapies for more effective treatments. The turnout indicates a strong interest in how microbubble technology can complement existing processes in cell therapy.
Conference Highlights and Presentations
Several notable presentations during the ASGCT will cover how microbubble technology enhances various aspects of cell therapy:
- Dr. Alex Sargent, Director of Process Development for Cell and Gene Therapy at Charles River Laboratories, will discuss a visionary presentation titled “Next Generation Cell Isolation: Replace Magnetics with Microbubbles”. This talk, scheduled for Thursday at 5 pm CT, promises insights into maximizing T cell recovery while reducing processing time.
- Results highlighting Akadeum's Human T Cell Leukopak Isolation Kit will be available during a session hosted by Lonza, which shows the significant improvements achieved by implementing microbubble technologies in their workflows.
- Attendees will gain firsthand experience with Akadeum’s innovative protocols at Booth #1748. Here, participants can explore new cell separation methods and learn how to efficiently integrate microbubbles in their laboratories.
About Akadeum Life Sciences
With a mission focused on improving human health through advanced separation technologies, Akadeum Life Sciences is committed to empowering scientists and clinicians alike. The company envisions innovations that enable pivotal breakthroughs in diagnostics and therapeutics. Their continuously refined, buoyancy-based separation technology stands at the forefront of cell isolation methods, promising higher efficiencies and scalability.
Frequently Asked Questions
What is microbubble technology?
Microbubble technology is an innovative cell separation method that utilizes buoyancy principles to efficiently isolate cells, promoting healthier outcomes.
How does Akadeum's technology reduce costs?
This technology allows for a streamlined manufacturing process, minimizing the operational footprint and enhancing efficiency, ultimately lowering costs.
Where will Akadeum present its findings?
Akadeum will present its latest advancements at the American Society of Gene & Cell Therapy conference, with multiple presentations scheduled throughout the event.
Can microbubble technology integrate into existing systems?
Yes, Akadeum’s microbubble technology is designed for seamless integration with various platforms, enhancing existing workflows.
What is the goal of Akadeum Life Sciences?
The company's primary mission is to improve human health through innovative separation technologies that facilitate breakthroughs in diagnostics and therapy development.
About The Author
Contact Dylan Bailey privately here. Or send an email with ATTN: Dylan Bailey as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.